Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV‐1 infection

S. Schwander, R. W. Braun, J. E. Kühn, F. T. Hufert, P. Kern, M. Dietrich, U. Wieland

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Two hundred twenty‐four sera were collected from 34 HIV‐1 infected patients during an observation period of up to 4.5 years (109 patient years of observation). The sera were tested for the presence of antibodies against the HIV‐1 virion infectivity factor (vif) protein. Thirty sera from 6 HIV‐1 seronegative individuals served as negative controls. The sera were immunoblotted against a recombinant, prokaryotically expressed vif protein. The prevalence of anti‐vif antibodies increased significantly with progression of the disease from 18% to 81% (P < 0.0001) which suggests a possible role of vif in HIV‐1 replication and pathogenicity.

Original languageEnglish (US)
Pages (from-to)142-146
Number of pages5
JournalJournal of Medical Virology
Volume36
Issue number2
DOIs
StatePublished - Feb 1992
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Virology

Keywords

  • AIDS
  • anti‐vif antibodies
  • prospective study
  • regulatory proteins
  • vif

Fingerprint

Dive into the research topics of 'Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV‐1 infection'. Together they form a unique fingerprint.

Cite this